Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 5,733

Document Document Title
WO/2022/168085A1
The present invention provides lipids and lipid nanoparticle formulations comprising these lipids, alone or in combination with other lipids. These lipid nanoparticles may be formulated with nucleic acids to facilitate their intracellula...  
WO/2022/158993A1
The present invention relates to a method for the production of d-erythro-sphingosine and analogs thereof, wherein the method comprises a step of condensing a compound of formula (2): Formula (2), or a salt thereof, wherein R1 is hydroge...  
WO/2022/148456A1
Pharmaceutical compositions comprising a chemotherapeutic agent based on a β-substituted β-amino acid derivative are disclosed. The pharmaceutical compositions include a β-substituted β-amino acid derivative and a cyclodextrin deriva...  
WO/2022/140518A1
A composition comprising a non-cationic amine epoxide adduct is disclosed, along with methods of making the same. Use of a composition comprising a non-cationic amine epoxide adduct on textiles and paper, particularly woven textiles, tis...  
WO/2022/134203A1
Disclosed is a novel method for preparing monoethanolamine, and the present invention belongs to the field of coal chemical engineering. The method of the present invention involves using methyl glycolate, which is an intermediate produc...  
WO/2022/132364A1
The present disclosure generally relates to a friction modifier comprising the reaction product of an organic amine and glycidol and its use in a non-aqueous lubricant composition. There is also provided a method for reducing the frictio...  
WO/2022/130403A1
The present invention relates to a new quaternary ammonium trifluoromethyl salts of formula (I), a process for the preparation thereof and its application in trifluoromethylation: (I) wherein, R1, R2, R3 and R4 are branched or linear C1-...  
WO/2022/133362A1
Disclosed are facile methods of purifying a cannabis extract to produce highly purified, crystallized cannabinoid acids, and in particular cannabinoid acids such as THCA, and removing impurities from the same, by using polar aprotic solv...  
WO/2022/129909A1
The present invention relates to a group of novel compounds, methods for their manufacture and the use of these compounds as research tools and as pharmaceuticals. The novel compounds are analogues of cannabidiol (CBD). CBD is a non-psyc...  
WO/2022/122931A1
A process for the removal of an inorganic salt from a feed liquid comprising an inorganic salt and an organic compound comprising a hydroxy group and/or an amine group, comprising passing the feed liquid through an electrodialysis (ED) u...  
WO/2022/121317A1
Disclosed is a 1,1'-biphenyl-2,6-diphenolic compound and the use thereof. The 1,1'-biphenyl-2,6-diphenolic compound is a new compound, and has good biological activity. By means of in vitro tumor cell activity experiments, it was found t...  
WO/2022/113098A1
The present invention relates to an environment-friendly process for selective acylation of aminophenol. In particular, the present invention relates to an environment-friendly process for selective acylation of para-aminophenol to obtai...  
WO/2022/099284A1
The present invention provides compositions comprising compounds having formulas (I), (II) or (III): and additionally provides methods for the use thereof in the treatment of various disorders including neurological disorders, cancer, di...  
WO/2022/087248A1
Disclosed herein are polymers formed by the condensation of bis(hydroxycarbyl)- aminophenolic compounds with aldehydes. The condensation polymers include one or more repeat units having bis(hydroxycarbyl)amino functionality. The hydroxyl...  
WO/2022/081777A1
A method of treating proteinuric kidney injury, comprising administering an effective isoLG scavenging amount of at least one compound of the present invention.  
WO/2022/073115A1
Compounds of Formula I or II, methods of preparation and of use thereof. Formula I has a core aromatic group with substituents as follows: Formula (I) wherein G1 is -(CH2)nC(R1)(R2)OH, -(CH2)n-CHO, -(CH2)nC(O)NR1R2, -(CH2)nCH (R1)NR1R2, ...  
WO/2022/069002A1
The invention relates to a compound, to a rubber mixture containing the compound, to a vehicle tire which has at least one component comprising the rubber mixture, to a method for producing the compound, and to the use of the compound as...  
WO/2022/061193A1
Provided are vitamin D3 derivatives of formula (I), pharmaceutical compositions thereof, and pharmaceutical or medical uses thereof for treating metabolic disease, a liver disease, obesity, diabetes, cardiovascular disease, or cancer in ...  
WO/2022/055781A1
There is disclosed a process for recovering monoethanolamine from an aqueous mother liquor solution comprising the steps of: (a) adding excess ammonia or alkali hydroxide and a solvent to the aqueous solution comprised of monoethanolamin...  
WO/2022/052683A1
The present invention provides a method for preparing a water-soluble magnolol derivative and a honokiol derivative, methods for preparing intermediates of a water-soluble magnolol derivative and a honokiol derivative, and a related mono...  
WO/2022/028557A1
A 18F-labeled biphenyl compound, an intermediate thereof, a preparation method therefor, a pharmaceutical composition thereof, and application thereof. The biphenyl compound has a significant suppression effect on PD-1 and/or PD-L1, can ...  
WO/2022/030447A1
A fluorinated diamine represented by general formula [1A] or a salt thereof; a polyamide including a structural unit derived from the diamine or salt; and a cyclized polyamide. In general formula [1A], R1 represents, or the multiple moie...  
WO/2022/020963A1
A method for the synthesis of specialized pro-resolving mediators, structural isomers thereof and analogs thereof is disclosed herein. The method comprises reacting a compound of the formula (I): (I) wherein R1 is alkyl(C≤12), cycloalk...  
WO/2022/022388A1
Provided is a dezocine derivative crystal form A. The X-ray powder diffraction spectrum of the crystal form A, expressed by a diffraction angle of 2θ±0.2°, shows characteristic peaks at 8.894, 9.496, 10.974, 13.334, 15.338, 15.942, 17...  
WO/2022/011792A1
The present invention provides a diquaternary ammonium salt intermediate preparation process, comprising: reacting a 1,3-Dichloro-2-propanol and a long carbon chain dimethylamine in acetone, producing the diquaternary ammonium salt inter...  
WO/2022/009782A1
Polybenzoxazole having a structural unit represented by general formula [1]. In general formula [1], R1 is a tetravalent organic group represented by general formula [2], and R2 is a divalent organic group. In general formula [2]: the tw...  
WO/2022/009695A1
The present invention provides: an alkoxide compound represented by general formula (1); a thin film-forming material containing said compound; and a method for manufacturing a thin film. (In the formula, R1 and R2 each independently rep...  
WO/2022/004506A1
The present invention addresses the problem of providing a novel compound which has satisfactory solubility in solvents, has high storage stability (solution stability) during refrigeration or freeze storage, and is usable as a crosslink...  
WO/2022/001515A1
Disclosed is a preparation method for a cardanol modified polyamine curing agent having high anticorrosive performance, comprising subjecting cardanol, paraformaldehyde and an amine compound to a Mannich reaction, adding a water-soluble ...  
WO/2021/260118A1
The invention relates to mixtures of propoxylated 4-toluidines containing two or more different di- or tri-propoxylated or higher propoxylated p-toluidines in specific weight ratios, to methods for preparing them and to their use as poly...  
WO/2021/255180A1
The present invention relates to 2-aminoethanol, piperazine and L- lysine salts of Bempedoic acid and processes for the preparation thereof.  
WO/2021/251337A1
CB-7 exhibits a weak TLR7 inhibiting effect in normal mice. The present invention provides a novel compound with a stronger TLR7 inhibiting effect than CB-7, a pharmaceutically acceptable salt of said compound, or a prodrug of said compo...  
WO/2021/185072A9
Disclosed in the present invention are a crystal form of aromatic vinyl derivatives, and a preparation method therefor and the use thereof. Specifically disclosed in the present invention are crystal form A, crystal form B and crystal fo...  
WO/2021/236771A1
The present disclosure related to compounds that can be useful as inhibitors of PD-1, PD-Ll or the PD-1/PD-Ll interaction. Also disclosed herein are pharmaceutical compositions of that can include a compound of Formula (I), or a pharmace...  
WO/2021/236395A1
CB-0406 choline salt, especially in crystalline form and as an ansolvate, methods of preparing it, compositions containing it, and its pharmaceutical uses.  
WO/2021/233752A1
The present invention is directed to compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions comprisin...  
WO/2021/236759A2
This disclosure relates to crystalline bis(4-hydroxy-N,N-di-n-propyltryptammonium)fumarate tetrahydrate (4-HO-DPT fumarate-4H2O) and to crystalline 4-hydroxy-N,N-di-n-propyl-tryptammonium chloride (4-HO-DPT chloride). Compositions contai...  
WO/2021/236394A1
CB-0406 tromethamine salt, especially in crystalline form and as an ansolvate, methods of preparing it, compositions containing it, and its pharmaceutical uses.  
WO/2021/219647A1
The present invention relates to a method for preparing paracetamol continuously, comprising a nitration step or a nitrosation step so as to obtain p-nitrophenol or p-nitrosophenol, respectively. The p-nitrophenol or p-nitrosophenol can ...  
WO/2021/214762A1
The invention provides an isolated material, or a phenolate form of at least one phenol- containing active material, wherein the isolated material comprises one or more phenolate species and a counter ion (a cation) in the form of a meta...  
WO/2021/212880A1
Disclosed is a method for preparing nicotine, in particular, a method for preparing nicotine by using nicotinate as a starting material to undergo a five-step reaction. The specific synthetic steps comprise: (1) performing a condensation...  
WO/2021/206513A1
The present invention relates to a pharmaceutical composition for preventing or treating muscular weakness-related diseases, comprising alverine, 4-hydroxy alverine, a derivative thereof, or a pharmaceutically acceptable salt thereof. Wh...  
WO/2021/158637A9
Various aspects of the present invention relate to cationic latex emulsions, methods of making the same, various materials including the cationic latex emulsion such as asphalt emulsions, and methods of making the asphalt emulsions. A ca...  
WO/2021/193963A1
Provided is an absorption liquid for separating and recovering carbon dioxide from gas containing carbon dioxide, the absorption liquid containing an alkanolamine compound represented by formula (1) and accounting for 30-70 mass% of the ...  
WO/2021/175886A1
The present invention relates to a fusing agent, comprising a compound of formula (I), a three-dimensional (3D) printing kit including the compound of formula (I) and A method for three-dimensional (3D) printing, including selectively ap...  
WO/2021/163811A1
Provided herein are compositions including polymeric binder or a salt thereof, high molecular weight polymer, pharmaceutically active agent and a low molecular weight cross-linking agent, methods for using the compositions to coat a subs...  
WO/2021/152281A1
The invention relates to a Mannich base useful as an epoxy curative agent. In particular, the present invention is directed to a Mannich base derived from furfuryl alcohol, or a homopolymer or co-polymer thereof, an epoxy resin curative ...  
WO/2021/149502A1
Provided is a composition that has a suitable viscosity for coatability and discharge properties, can be fired at a low temperature, and yields an extremely small amount of ash after being fired. A composition according to the present ...  
WO/2021/150559A1
The invention provides methods for treating cancer in a patient comprising administering dosing regimens of (S,S)-(HO)2DEHSPM that unexpectedly reverse or reduce the onset of severe liver toxicity and improve patient safety profiles.  
WO/2021/130168A1
This invention relates to an ophthalmic formulation comprising lifitegrast, an amino compound, a tonicity-adjusting agent and water, wherein the formulation has an osmolality of 150-330 mOsm/kg. The invention also relates to lifitegrast ...  

Matches 1 - 50 out of 5,733